Mytos builds robots that grow human cells. Our machines take stem cells as input, and grow them into specific cells like neurons or heart cells.
Customers use our platform to scale stem-cell derived therapies to more patients sooner. We're also used to produce cells for testing new drugs on during R&D in Drug Discovery.
Mytos is backed by leading investors, including YCombinator, Buckley Ventures and IQ Capital - as well as founders and execs from companies like Kite, Sana, Dropbox, and Revolut. Our team is made up of brilliant engineers from companies like Dyson and Autodesk - working hand-in-hand with Nature-published scientists.
We're hiring now - visit our website to see open positions
Company Details
- Employees
- 47
- Founded
- -
- Address
- 80 Wood Lane, London,england,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.mytos.bio
- HQ
- London, England
Mytos Questions
Mytos's website is https://www.mytos.bio
Mytos's LinkedIn profile is https://www.linkedin.com/company/mytosbio
Mytos has
47 employees.
View email and phone details for 47
employees at Mytos.
Mytos's industry is
Biotechnology Research
Mytos's top competitors are
Aspen Neuroscience, Inc.,
Cellworks,
Autolus Therapeutics,
Orchard Therapeutics - U.s.,
Isomorphic Labs,
Techruiter.,
Mina Therapeutics,
Relation,
Labgenius Therapeutics,
Quell Therapeutics.
Mytos's categories are Biotechnology Research
Mytos's founding year is 2016
